This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Moeremans K, Lamotte M, Wittrup-Jensen KU, Pignone M.The health economic value of aspirin in the primary prevention of cardiovascular disease in diabetic patients. 69th Annual Scientific Sessions of the American Diabetes Association: 12 abstr. 44-OR, 5 Jun 2009. Available from: URL: http://ww2.aievolution.com
Rights and permissions
About this article
Cite this article
Low-dose aspirin cost saving in CVD. Pharmacoecon. Outcomes News 582, 4 (2009). https://doi.org/10.2165/00151234-200905820-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905820-00008